Skip to main content

and
  1. Article

    Open Access

    Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma

    A novel somatostatin analogue, TT-232 (which inhibits the proliferation of various cell cultures and transplantable mouse tumours), was examined regarding its effect on human melanoma and lymphoma xenografts a...

    B Szende, A Horváth, G Bökönyi, G Kéri in British Journal of Cancer (2003)

  2. Article

    Open Access

    Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers

    Insulin-like growth factors (IGFs) I and II are implicated in progression of various tumours including colorectal carcinomas. To interfere with the production of IGFs, we treated male nude mice bearing xenogra...

    K Szepeshazi, A V Schally, K Groot, P Armatis, G Halmos in British Journal of Cancer (2000)

  3. No Access

    Article

    Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats

    The possible protective effect of an agonist of luteinising hormone-releasing hormone (LH-RH) against the ovarian damage caused by cyclophosphamide was investigated in rats. D-Trp6-LH-RH microcapsules were inj...

    L Bokser, B Szende, AV Schally in British Journal of Cancer (1990)

  4. No Access

    Article

    A Transferable “Resistance Factor” from in vitro Cultured MDMS-Resistant Yoshida Sarcoma Cells

    Cells of the methylene dimethanesulphonate-(MDMS)-resistant Yoshida sarcoma cell line contain a low molecular weight “resistance factor” which is present in the culture medium of these cells and may be utilize...

    B Szende, M Fox, B W Fox in British Journal of Cancer (1973)